2024 Q3 Form 10-Q Financial Statement

#000101376224000546 Filed on July 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024 Q1
Revenue $3.000K $47.00K $56.00K
YoY Change 370.0% 8932.26%
Cost Of Revenue -$18.00K -$47.00K $70.00K
YoY Change -122.5% -413.33% 117.59%
Gross Profit $21.00K -$14.00K
YoY Change -126.25% -55.63%
Gross Profit Margin 700.0% -25.0%
Selling, General & Admin $2.255M $374.0K $1.873M
YoY Change 559.36% -26.38% 208.3%
% of Gross Profit 10738.1%
Research & Development $239.0K $310.0K $750.0K
YoY Change -16.72% 49.76% 256.58%
% of Gross Profit 1138.1%
Depreciation & Amortization $40.00K $25.00K $26.00K
YoY Change 53.85% -3.85% 25.73%
% of Gross Profit 190.48%
Operating Expenses $2.494M $684.0K $2.623M
YoY Change 296.5% -4.34% 220.72%
Operating Profit -$2.473M -$684.0K -$2.637M
YoY Change 248.8% -5.0% 210.45%
Interest Expense $289.0K $275.0K -$1.456M
YoY Change -29.85% -35.75% -7113.49%
% of Operating Profit
Other Income/Expense, Net $2.000K $441.0K
YoY Change -71.43% 44000.0%
Pretax Income -$6.390M -$15.26M -$4.216M
YoY Change 470.54% 1237.42% 409.4%
Income Tax
% Of Pretax Income
Net Earnings -$6.390M -$15.26M -$4.216M
YoY Change 470.54% 1237.25% 409.4%
Net Earnings / Revenue -213000.0% -32463.83% -7528.57%
Basic Earnings Per Share -$0.06 -$0.14
Diluted Earnings Per Share -$0.06 -$0.14 -$0.04
COMMON SHARES
Basic Shares Outstanding 111.5M shares 109.0M shares 102.0M shares
Diluted Shares Outstanding 111.4M shares 106.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.00K $297.0K $124.0K
YoY Change -71.15% 494.0% 726.67%
Cash & Equivalents $15.00K $297.0K $124.0K
Short-Term Investments
Other Short-Term Assets $83.00K $140.0K $175.0K
YoY Change 196.43% 8.53% 23.24%
Inventory $33.00K $20.00K
Prepaid Expenses
Receivables $16.00K $15.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $147.0K $452.0K $319.0K
YoY Change -18.78% 32.55% 2.24%
LONG-TERM ASSETS
Property, Plant & Equipment $701.0K $710.0K $378.0K
YoY Change 63.02% 55.02% -18.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $160.0K $160.0K $160.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.357M $1.429M $1.145M
YoY Change 3.83% 3.18% -20.32%
TOTAL ASSETS
Total Short-Term Assets $147.0K $452.0K $319.0K
Total Long-Term Assets $1.357M $1.429M $1.145M
Total Assets $1.504M $1.881M $1.464M
YoY Change 1.08% 8.98% -16.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.398M $2.407M $2.625M
YoY Change -8.51% -12.85% 13.29%
Accrued Expenses $2.246M $1.948M $2.598M
YoY Change 5.5% 8.58% 41.97%
Deferred Revenue
YoY Change
Short-Term Debt $6.533M $5.783M $4.528M
YoY Change
Long-Term Debt Due $927.0K $945.0K $4.751M
YoY Change -89.94% -89.74% -48.41%
Total Short-Term Liabilities $33.35M $28.70M $15.19M
YoY Change 127.89% 98.88% 8.28%
LONG-TERM LIABILITIES
Long-Term Debt $7.656M $8.449M $7.374M
YoY Change 6.07% 16.73% 0.72%
Other Long-Term Liabilities $268.0K $358.0K $423.0K
YoY Change -50.83% -40.63% -35.91%
Total Long-Term Liabilities $7.924M $8.807M $7.797M
YoY Change 2.07% 12.32% -2.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.35M $28.70M $15.19M
Total Long-Term Liabilities $7.924M $8.807M $7.797M
Total Liabilities $41.27M $37.51M $22.98M
YoY Change 84.28% 68.41% 4.44%
SHAREHOLDERS EQUITY
Retained Earnings -$500.6M -$494.2M -$479.0M
YoY Change 4.95% 3.85% 0.89%
Common Stock $460.9M $458.6M $457.5M
YoY Change 4608580.0% 5095688.89% 5082900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.77M -$35.63M -$21.50M
YoY Change
Total Liabilities & Shareholders Equity $1.504M $1.881M $1.464M
YoY Change 1.08% 8.98% -16.3%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$6.390M -$15.26M -$4.216M
YoY Change 470.54% 1237.25% 409.4%
Depreciation, Depletion And Amortization $40.00K $25.00K $26.00K
YoY Change 53.85% -3.85% 25.73%
Cash From Operating Activities -$835.0K -$784.0K -$817.0K
YoY Change 13.61% -1.63% -5.99%
INVESTING ACTIVITIES
Capital Expenditures $31.00K $36.00K -$1.000K
YoY Change -3200.0% 3500.0% 426.32%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$31.00K -$36.00K $1.000K
YoY Change -3200.0% 3500.0% 426.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 584.0K $993.0K 895.0K
YoY Change -20.65% 19.21% 37.66%
NET CHANGE
Cash From Operating Activities -835.0K -$784.0K -817.0K
Cash From Investing Activities -31.00K -$36.00K 1.000K
Cash From Financing Activities 584.0K $993.0K 895.0K
Net Change In Cash -282.0K $173.0K 79.00K
YoY Change -14200.0% 380.56% -136.13%
FREE CASH FLOW
Cash From Operating Activities -$835.0K -$784.0K -$817.0K
Capital Expenditures $31.00K $36.00K -$1.000K
Free Cash Flow -$866.0K -$820.0K -$816.0K
YoY Change 17.98% 2.76% -6.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106140039 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96036536 shares
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-05-31
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
AURA SYSTEMS, INC.
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4106894
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
20431 North Sea Circle
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Lake Forest
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92630
CY2024Q2 dei City Area Code
CityAreaCode
(310)
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
643-5300
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111527248 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
20000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
140000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
175000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
452000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
319000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
710000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
378000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
559000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
607000 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
160000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
160000 usd
CY2024Q2 us-gaap Assets
Assets
1881000 usd
CY2024Q1 us-gaap Assets
Assets
1464000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2407000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2625000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1702000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
2598000 usd
CY2024Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
447000 usd
CY2024Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
447000 usd
CY2024Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
163000 usd
CY2024Q1 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
119000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1513000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1508000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
246000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
238000 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17171000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
28701000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
15187000 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
438000 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
286000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
358000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
423000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
37508000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
22984000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109047248 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109047248 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104591648 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104591648 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
458610000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
457460000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494248000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-478990000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-35627000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-21520000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1881000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1464000 usd
CY2024Q2 us-gaap Revenues
Revenues
47000 usd
CY2023Q2 us-gaap Revenues
Revenues
10000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-47000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-5000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
310000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
207000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
374000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
508000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
684000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
715000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-684000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-720000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
275000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
428000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19324000 usd
CY2024Q2 ausi Change In Fair Value Derivative Liability
ChangeInFairValueDerivativeLiability
-5023000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15258000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1141000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106140039 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96036536 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-20258000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
853000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1141000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20546000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-21520000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1117000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
33000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15258000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-35627000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15258000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1141000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26000 usd
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
20000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19324000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5023000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-35000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9000 usd
CY2024Q2 ausi Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-48000 usd
CY2023Q2 ausi Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-49000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-218000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
335000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
345000 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-57000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-50000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-784000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-797000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1117000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
853000 usd
CY2024Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
124000 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
993000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
833000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
173000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
35000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
67000 usd
CY2024Q2 ausi Fair Value Of Modified Warrants Related Party
FairValueOfModifiedWarrantsRelatedParty
33000 usd
CY2024Q2 ausi Notes Payable Issued For The Purchase Of Property And Equipment
NotesPayableIssuedForThePurchaseOfPropertyAndEquipment
321000 usd
CY2024Q2 ausi Fair Value Of Warrants Issued For Note Payable
FairValueOfWarrantsIssuedForNotePayable
9261000 usd
CY2024Q2 ausi Extinguishment Of Note Payable And Accrued Interest Related Party
ExtinguishmentOfNotePayableAndAccruedInterestRelatedParty
12164000 usd
CY2024Q2 ausi Conversion Feature Of Convertible Note Payable Related Party Accounted As Derivative Liability
ConversionFeatureOfConvertibleNotePayableRelatedPartyAccountedAsDerivativeLiability
22194000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15258000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-784000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-35627000 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates include assumptions made for inventory valuation, impairment testing of long-lived assets, the valuation allowance for deferred tax assets, assumptions used in valuing notes payable, derivative liabilities, assumptions used in valuing share-based compensation, and accruals for potential liabilities. Amounts could materially change in the future. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Vendor Concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of May 31, 2024 , four vendors accounted for 39%, 12%, 11% and 10% of the Company’s accounts payable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of February 29, 2024, four vendors accounted for 42%, 11%, 11% and 10% of accounts payable.</p>
CY2024Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
17171000 usd
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17171000 usd
CY2024Q2 ausi Recognition Of Derivative Liability From Conversion Feature Of A Note Payable
RecognitionOfDerivativeLiabilityFromConversionFeatureOfANotePayable
22194000 usd
CY2024Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-5023000 usd
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
17171000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57527671 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12500209 shares
CY2024Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
110000 usd
CY2024Q2 us-gaap Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
0.2
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
12281000 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3020000 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
9261000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
601000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
405000 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
163000 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
119000 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
438000 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
286000 usd
CY2024Q2 ausi Paid Fee
PaidFee
74285 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
47000 usd
CY2024Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000 usd
CY2024Q2 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
232000 usd
CY2022Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
1051000 usd
CY2023Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.06 pure
CY2022Q2 ausi Installment Paid
InstallmentPaid
150000 usd
CY2023Q1 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.06 pure
CY2022Q1 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10 day
CY2022Q1 ausi Percentage Of Remit Cash Proceeds Equal To Revenues And Debt Or Equity
PercentageOfRemitCashProceedsEqualToRevenuesAndDebtOrEquity
0.20 pure
CY2024Q2 ausi Required To Payment
RequiredToPayment
0.20 pure
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.85
CY2022Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.5
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19324000 usd
CY2024Q2 ausi Fair Value Of Warrants Issued For Note Payable
FairValueOfWarrantsIssuedForNotePayable
9261000 usd
CY2024Q2 ausi Fair Value Of Modified Warrants Related Party
FairValueOfModifiedWarrantsRelatedParty
33000 usd
CY2024Q2 ausi Notes Payable And Accrued Interest
NotesPayableAndAccruedInterest
12164 usd
CY2024Q2 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.10 pure
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1702000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
2598000 usd
CY2024Q2 us-gaap Area Of Land
AreaOfLand
18000 sqft
CY2024Q2 us-gaap Payments For Rent
PaymentsForRent
22000 usd
CY2024Q2 ausi Lease Rent Percentage
LeaseRentPercentage
0.03 pure
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.10 pure
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
69000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
70000 usd
CY2024Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
72000 usd
CY2023Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
71000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
559000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
246000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
358000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
604000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
225000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
299000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
155000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
679000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
68000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
604000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
382000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3521664 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.83
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3000000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6521664 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.77
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3000000 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2024Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2023Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
36000 usd
CY2022Q2 srt Interest Bearing Liabilities Average Rate Paid
InterestBearingLiabilitiesAverageRatePaid
0.10 pure
CY2019Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
27500000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 us-gaap Inventory Net
InventoryNet
usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
usd
CY2023Q2 ausi Change In Fair Value Derivative Liability
ChangeInFairValueDerivativeLiability
usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q2 ausi Fair Value Of Modified Warrants Related Party
FairValueOfModifiedWarrantsRelatedParty
usd
CY2023Q2 ausi Notes Payable Issued For The Purchase Of Property And Equipment
NotesPayableIssuedForThePurchaseOfPropertyAndEquipment
usd
CY2023Q2 ausi Fair Value Of Warrants Issued For Note Payable
FairValueOfWarrantsIssuedForNotePayable
usd
CY2023Q2 ausi Extinguishment Of Note Payable And Accrued Interest Related Party
ExtinguishmentOfNotePayableAndAccruedInterestRelatedParty
usd
CY2023Q2 ausi Conversion Feature Of Convertible Note Payable Related Party Accounted As Derivative Liability
ConversionFeatureOfConvertibleNotePayableRelatedPartyAccountedAsDerivativeLiability
usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
usd
CY2024Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2024Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000826253
CY2024Q2 dei Entity File Number
EntityFileNumber
0-00000

Files In Submission

Name View Source Status
0001013762-24-000546-index-headers.html Edgar Link pending
0001013762-24-000546-index.html Edgar Link pending
0001013762-24-000546.txt Edgar Link pending
0001013762-24-000546-xbrl.zip Edgar Link pending
ausi-20240531.xsd Edgar Link pending
ea0209741-10q_aurasystem.htm Edgar Link pending
ea020974101ex31-1_aurasys.htm Edgar Link pending
ea020974101ex31-2_aurasys.htm Edgar Link pending
ea020974101ex32-1_aurasys.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ausi-20240531_def.xml Edgar Link unprocessable
ausi-20240531_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0209741-10q_aurasystem_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ausi-20240531_cal.xml Edgar Link unprocessable
ausi-20240531_lab.xml Edgar Link unprocessable